BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31754336)

  • 1. Evaluation of the effects of sequence length and microsatellite instability on single-guide RNA activity and specificity.
    Zhao C; Wang Y; Nie X; Han X; Liu H; Li G; Yang G; Ruan J; Ma Y; Li X; Cheng H; Zhao S; Fang Y; Xie S
    Int J Biol Sci; 2019; 15(12):2641-2653. PubMed ID: 31754336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
    Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
    PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of CRISPR/Cas9 sgRNA Design Tools.
    Cui Y; Xu J; Cheng M; Liao X; Peng S
    Interdiscip Sci; 2018 Jun; 10(2):455-465. PubMed ID: 29644494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.
    Labuhn M; Adams FF; Ng M; Knoess S; Schambach A; Charpentier EM; Schwarzer A; Mateo JL; Klusmann JH; Heckl D
    Nucleic Acids Res; 2018 Feb; 46(3):1375-1385. PubMed ID: 29267886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency.
    Hiranniramol K; Chen Y; Liu W; Wang X
    Bioinformatics; 2020 May; 36(9):2684-2689. PubMed ID: 31971562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.
    Tran MTN; Khalid MKNM; Pébay A; Cook AL; Liang HH; Wong RCB; Craig JE; Liu GS; Hung SS; Hewitt AW
    Mol Vis; 2019; 25():174-182. PubMed ID: 30996586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm.
    Zhou H; Zhou M; Li D; Manthey J; Lioutikova E; Wang H; Zeng X
    BMC Genomics; 2017 Nov; 18(Suppl 9):826. PubMed ID: 29219081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
    Prykhozhij SV; Rajan V; Gaston D; Berman JN
    PLoS One; 2015; 10(3):e0119372. PubMed ID: 25742428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Meets In Vivo: Towards Computational CRISPR-Based sgRNA Design.
    Chuai GH; Wang QL; Liu Q
    Trends Biotechnol; 2017 Jan; 35(1):12-21. PubMed ID: 27418421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In silico CRISPR-based sgRNA design].
    Wang Y; Chuai G; Yan J; Shi L; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1744-1756. PubMed ID: 29082722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.
    Zhang Q; Xing HL; Wang ZP; Zhang HY; Yang F; Wang XC; Chen QJ
    Plant Mol Biol; 2018 Mar; 96(4-5):445-456. PubMed ID: 29476306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
    Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
    FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3'-terminal segment of guide RNA.
    Mekler V; Minakhin L; Semenova E; Kuznedelov K; Severinov K
    Nucleic Acids Res; 2016 Apr; 44(6):2837-45. PubMed ID: 26945042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized CRISPR/Cas9 system for gene knockout in chicken DF1 cells.
    Zou K; Wang F; Zhang Z; Zhou Y; Li P; Wang D; Zhu M; Jia C; Wei Z
    Poult Sci; 2023 Oct; 102(10):102970. PubMed ID: 37562129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.